| Primary |
| Diagnostic Procedure |
50.0% |
| Product Used For Unknown Indication |
29.0% |
| Abdominal Pain |
3.1% |
| Pain Management |
2.6% |
| Lung Neoplasm Malignant |
2.1% |
| Hypertension |
1.6% |
| Chest Pain |
1.2% |
| Back Pain |
1.0% |
| Abdominal Pain Lower |
0.9% |
| Abdominal Pain Upper |
0.9% |
| Computerised Tomogram |
0.9% |
| Malignant Melanoma |
0.9% |
| Non-alcoholic Steatohepatitis |
0.9% |
| Pulmonary Embolism |
0.9% |
| Fluid Replacement |
0.7% |
| Headache |
0.7% |
| Osteoporosis |
0.7% |
| Routine Health Maintenance |
0.7% |
| Breast Cancer |
0.6% |
| Cancer Pain |
0.6% |
|
| Urticaria |
19.7% |
| Vomiting |
13.6% |
| Meningitis Fungal |
8.3% |
| No Adverse Event |
7.9% |
| Rash |
5.3% |
| Pruritus |
4.8% |
| Pyrexia |
4.8% |
| Renal Failure Acute |
3.9% |
| Throat Irritation |
3.5% |
| Throat Tightness |
3.5% |
| Extravasation |
3.1% |
| Tremor |
3.1% |
| Erythema |
2.6% |
| Loss Of Consciousness |
2.6% |
| Rash Maculo-papular |
2.6% |
| Anaphylactoid Shock |
2.2% |
| Oxygen Saturation Decreased |
2.2% |
| Shock |
2.2% |
| Sneezing |
2.2% |
| Anaphylactic Reaction |
1.8% |
|
| Secondary |
| Diagnostic Procedure |
46.7% |
| Product Used For Unknown Indication |
33.1% |
| Abdominal Pain |
2.5% |
| Pain Management |
2.3% |
| Hypertension |
1.6% |
| Lung Neoplasm Malignant |
1.6% |
| Chest Pain |
1.4% |
| Abdominal Pain Upper |
1.1% |
| Routine Health Maintenance |
1.1% |
| Percutaneous Coronary Intervention |
1.0% |
| Dyspnoea |
0.9% |
| Malignant Melanoma |
0.9% |
| Acute Myocardial Infarction |
0.8% |
| Computerised Tomogram |
0.8% |
| Headache |
0.8% |
| Non-alcoholic Steatohepatitis |
0.8% |
| Nuclear Magnetic Resonance Imaging Abdominal |
0.8% |
| Back Pain |
0.6% |
| Breast Cancer |
0.6% |
| Fluid Replacement |
0.6% |
|
| Urticaria |
19.5% |
| Vomiting |
10.4% |
| Meningitis Fungal |
8.6% |
| No Adverse Event |
7.2% |
| Pruritus |
5.4% |
| Rash |
4.5% |
| Throat Irritation |
4.5% |
| Tremor |
4.5% |
| Drug Reaction With Eosinophilia And Systemic Symptoms |
4.1% |
| Rash Maculo-papular |
4.1% |
| Blood Creatinine Increased |
3.2% |
| Pyrexia |
3.2% |
| Throat Tightness |
3.2% |
| Erythema |
2.7% |
| Extravasation |
2.7% |
| Loss Of Consciousness |
2.7% |
| Renal Failure Acute |
2.7% |
| Anaphylactoid Shock |
2.3% |
| Oxygen Saturation Decreased |
2.3% |
| Renal Tubular Necrosis |
2.3% |
|
| Concomitant |
| Low Back Pain |
18.9% |
| Therapeutic Embolisation |
17.0% |
| Acute Lymphocytic Leukaemia |
11.3% |
| Prophylaxis |
9.4% |
| Pain |
4.7% |
| Product Used For Unknown Indication |
4.7% |
| Osteoporosis |
3.8% |
| Anaesthesia |
2.8% |
| Chronic Hepatitis C |
2.8% |
| Coronary Artery Bypass |
2.8% |
| Head And Neck Cancer |
2.8% |
| Insomnia |
2.8% |
| Lumbar Radiculopathy |
2.8% |
| Back Pain |
1.9% |
| Colitis Ulcerative |
1.9% |
| Computerised Tomogram |
1.9% |
| Constipation Prophylaxis |
1.9% |
| Gastritis |
1.9% |
| Hepatic Cirrhosis |
1.9% |
| Hepatic Neoplasm Malignant |
1.9% |
|
| Meningitis |
31.0% |
| Hospitalisation |
11.9% |
| Vaginal Haemorrhage |
7.1% |
| Cholecystitis Acute |
4.8% |
| Nuclear Magnetic Resonance Imaging |
4.8% |
| Renal Failure Acute |
4.8% |
| Unevaluable Event |
4.8% |
| Bradycardia |
2.4% |
| Cerebrovascular Accident |
2.4% |
| Dehydration |
2.4% |
| Dyspnoea |
2.4% |
| Enterocolitis |
2.4% |
| Headache |
2.4% |
| International Normalised Ratio Increased |
2.4% |
| Malaise |
2.4% |
| Neck Pain |
2.4% |
| Oedema |
2.4% |
| Photophobia |
2.4% |
| Pneumonia |
2.4% |
| Pyrexia |
2.4% |
|
| Interacting |
| Drug Use For Unknown Indication |
100.0% |
|
| Renal Tubular Necrosis |
100.0% |
|
